4
Changes in Ownership
INSMED Inc Filed Acc 0001628280-25-013864
Chair and CEO sold 25,580 shares at an average $77.03 ($1,970,421)
- Chair and CEO acquired 25,580 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lewis William · Chair and CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +18,750 | $22.76 | $426,750 | 352,936 | D |
| 2025-03-17 | Sale : show line 2 in the form 10b5-1 | −4,727 | $75.91 | $358,827 | 348,209 | D |
| 2025-03-17 | Sale : show line 3 in the form 10b5-1 | −5,907 | $76.87 | $454,071 | 342,302 | D |
| 2025-03-17 | Sale : show line 4 in the form 10b5-1 | −8,116 | $77.79 | $631,344 | 334,186 | D |
| 2025-03-17 | Exercise or conversion : show line 5 in the form 10b5-1 | +6,830 | $10.85 | $74,106 | 240,754 | I |
| 2025-03-17 | Sale : show line 6 in the form 10b5-1 | −2,023 | $76.00 | $153,748 | 238,731 | I |
| 2025-03-17 | Sale : show line 7 in the form 10b5-1 | −2,070 | $77.01 | $159,411 | 236,661 | I |
| 2025-03-17 | Sale : show line 8 in the form 10b5-1 | −2,737 | $77.83 | $213,021 | 233,924 | I |
| Open-market sales · 25,580 sh · avg $77.03 · $1,970,421 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-17 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) | −18,750 | 0 | D |
| 2025-03-17 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (right to buy) | −6,830 | 191,310 | I |
Loading xslF345X05/wk-form4_1742417573.xml…